GLP-1 Makers Sued Over Rare Sudden Vision Loss
Thousands of patients say the companies failed to warn them about a rare eye stroke linked to sudden, sometimes permanent vision loss.
- Dozens of patients have filed Lawsuits against drugmakers Novo and Eli Lilly, alleging the companies failed to warn users about sudden vision loss from GLP-1s including Ozempic, Wegovy, Mounjaro, and Zepbound.
- Non-Arteritic anterior ischaemic optic neuropathy, or NAION, is a rare condition that can lead to sudden and sometimes permanent vision loss due to lack of blood flow to the optic nerve.
- Research involving more than 159,000 participants with type 2 diabetes found 35 cases of NAION among GLP-1 users compared to 19 in the comparison group; researchers also identified 93 patients with 'Other optic nerve disorders.'
- Similar Lawsuits against Eli Lilly are currently pending, with plaintiffs claiming the company failed to adequately warn patients of risks associated with their weight-loss and diabetes treatments.
- The American Academy of Ophthalmology encourages clinicians and patients to make 'informed choices' regarding GLP-1s, while noting that studies show modest risk but fewer patients experienced sight-threatening complications from diabetes.
162 Articles
162 Articles
Lawsuits Allege GLP-1 Drugs Can Cause Blindness
USA Today reports: Lawsuits are piling up against major GLP-1 makers Eli Lilly and Novo Nordisk as more patients accuse popular drugs like Ozempic and Zepbound of permanently damaging their eyesight. A series of complaints filed within the last year focus on a specific condition called non-arteritic anterior ischemic optic neuropathy, or NAION, which causes … The post Lawsuits Allege GLP-1 Drugs Can Cause Blindness appeared first on Joe.My.God..
Syracuse NY
Ozempic, Wegovy users sue over rare, permanent blindness
In recent years, GLP-1 medications such as Ozempic, Wegovy, Mounjaro and Zepbound have dominated headlines for helping people lose weight — but now those same drugs are making headlines for a different reason.
Twelve people claim to have been completely blinded after using Ozempic, Wegovy or Zepbound. The lawsuit they filed this week against Novo Nordisk and Eli Lilly reopened a question that millions of patients across the country and the region have been asked since these drugs became a global phenomenon: how safe are LPG-1s really? To answer this question, Dr. Alfredo Melgar, internist doctor and director of nursing homes in Miami-Dade County, expl…
Ozempic and Wegovy face numerous lawsuits over rare ‘eye stroke’ linked to vision loss
Hundreds of patients are suing the makers of popular GLP-1 weight-loss drugs, alleging the medicines raised their risk of a rare “eye stroke” that can steal sight for good. The lawsuits claim the drugs caused NAION—nonarteritic anterior ischemic optic neuropathy—according to The Wall Street Journal. In NAION, blood flow to the optic nerve drops suddenly […]
Can GLP-1 drugs cause blindness? Hundreds of lawsuits say yes
A growing number of lawsuits in Arizona and New Jersey claim GLP-1 drugs such as Ozempic and Wegovy cause permanent vision loss. Dozens of lawsuits alleging permanent vision loss have been filed in Arizona against Eli Lilly, the maker of Ozempic and Wegovy, and Novo Nordisk, maker of Zepbound. GLP-1 drugs are prescribed for weight […]
Coverage Details
Bias Distribution
- 71% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
